Monoamine Oxidase

Monoamine Oxidase

A family of enzymes known as monoamine oxidases (MAO) catalyzes the oxidation of monoamines. In the majority of the body's cell types, they are discovered bound to the mitochondria's outer membrane. They are a member of the flavin-containing amine oxidoreductase protein family. The oxidative deamination of monoamines is catalyzed by monoamine oxidases. By using oxygen to remove an amine group from a molecule, the resulting aldehyde and ammonia are produced.Flavoproteins are monoamine oxidases because they have the cofactor FAD covalently bound to them. MAO dysfunction is thought to be the cause of a number of psychiatric and neurological disorders due to the critical part MAOs play in the inactivation of neurotransmitters. While MAO-B inhibitors are used alone or in combination to treat Alzheimer's and Parkinson's diseases, MAO-A inhibitors have antidepressant and antianxiety properties.

Monoamine Oxidase related products

Structure Cat No. Product Name CAS No. Product Description
V70682 MAO-B-IN-10 2376710-36-8 MAO-B-IN-10 (compound 4f) is a specific, BBB (blood-brain barrier) penetrating MAO-B (monoamine oxidase-B) inhibitor (antagonist) with IC50 of 5.3 μM.
V70689 MAO-B-IN-17 2890188-81-3 MAO-B-IN-17 is a selective monoamine oxidase B (MAO-B) inhibitor (antagonist) with IC50 of 5.08 μM and may be utilized in the study of PD/Parkinson's disease.
V79013 MAO-B-IN-18 MAO-B-IN-18 is a potent and specific MAO B inhibitor (antagonist) with IC50 of 52 nM and 14 μM for hMAO B and hMAO A respectively.
V70646 MAO-B-IN-2 1253978-24-3 MAO-B-IN-2 is a selective and competitive inhibitor of MAO-B and BChE with IC50s of 0.51 and 7.00 μM, respectively.
V79879 MAO-B-IN-20 MAO-B-IN-20 (Compound C14) is a potent inhibitor of MAO-B with IC50 of 0.037 μM.
V70699 MAO-B-IN-21 2956426-18-7 MAO-B-IN-21 is a potent MAO-B inhibitor (antagonist) with anti-oxidant effect and anti-Aβ aggregation activity.
V70663 MAO-B-IN-23 2107978-22-1 MAO-B-IN-23 (Compound 11f) is a reversible and competitive MAO-B inhibitor (IC50= 1.44 μM, Ki= 0.51 μM).
V80681 MAO-B-IN-25 MAO-B-IN-25 (compound 92) is a selective MAO-B inhibitor (antagonist) with IC50s of 0.5 nM and 240 nM for MAO-A and MAO-B, respectively.
V70656 MAO-B-IN-27 788824-83-9 MAO-B-IN-27 (Compound 12c) is a monoamine oxidase B (MAO-B) inhibitor.
V79144 MAO-B-IN-3 MAO-B-IN-3 is a reversible and selective MAO-B inhibitor (IC50=96 nM).
V80682 MAO-B-IN-4 MAO-B-IN-4 (Compound 26) is an orally bioactive, reversible inhibitor of MAO-B with IC50 of 9 nM.
V70655 MAO-IN-3 797805-26-6 MAO-IN-3 (Compound 5) is a reversible and competitive inhibitor of MAO (Ki: 0.6 and 0.2 μM for MAO A and MAO B, respectively).
V70683 MAO-IN-M30 dihydrochloride 64821-19-8 MAO-IN-M30 di-HCl is an orally bioactive, BBB (blood-brain barrier)-passing, brain-selective and irreversible inhibitor of MAO-A (IC50=37 nM) and MAO-B (IC50=57 nM).
V80680 MAOA-IN-1 MAOA-IN-1 (compound 15) is an orally bioavailable MAOA inhibitor (antagonist) with cytotoxic effect against prostate cancer cells.
V70665 Mebanazine 65-64-5 Mebanazine is a potent MAO (monoamine oxidase) inhibitor.
V70690 Methyl citrate 26163-61-1 Methyl citrate is a monoamine oxidase B (MAO-B) inhibitor (IC50=0.23 mM).
V70697 Methyl piperate 6190-46-1 Methylpiperate is a piperine alkaloid with significant MAO inhibitory activity (IC50 3.6 μM).
V25757 Mofegiline HCl 120635-25-8 Mofegiline HCl(MDL-72,974; MDL72,974), the hydrochloride salt ofMofegiline, is a potent andirreversibleinhibitor of monoamine oxidase B (MAO-B) and semicarbazide-sensitive amine oxidase (SSAO)with the potential to be used for the treatment for various diseases.
V70675 Monoamine oxidase 9001-66-5 Monoamine oxidase is an enzyme consisting of different polypeptides.
V70687 Monoamine Oxidase B inhibitor 1 2807477-70-7 Monoamine Oxidase B inhibitor 1 is a potent, reversible, orally bioactive and selective inhibitor of monoamine oxidase B (MAO-B) with IC50 of 0.02 nM.
Contact Us Back to top